Jianwei W. Zhang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Bidirectional beam deflection induced by the local phase transition through field-driven dynamics of polar nanoregions.

Bidirectional beam deflection induced by the local phase transition through field-driven dynamics of polar nanoregions.

Journal: Optics express

Published: May 04, 2026

Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2).

Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2).

Journal: Med (New York, N.Y.)

Published: March 11, 2026

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: February 25, 2026

ASO Visual Abstract: Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients With Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trials.

ASO Visual Abstract: Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients With Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trials.

Journal: Annals of surgical oncology

Published: February 13, 2026

PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.

PTEN deficiency impairs MHC-I-mediated tumour immunity via NRF2-dependent autophagy in microsatellite stable colorectal cancer.

Journal: Gut

Published: January 19, 2026

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial.

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial.

Journal: EClinicalMedicine

Published: July 28, 2025

Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer.

Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer.

Journal: Cell reports. Medicine

Published: June 23, 2025

Fine-Grained Hierarchical Progressive Modal-Aware Network for Brain Tumor Segmentation.

Fine-Grained Hierarchical Progressive Modal-Aware Network for Brain Tumor Segmentation.

Journal: IEEE journal of biomedical and health informatics

Published: May 22, 2025

Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study.

Glycolysis-Driven Immune Evasion in Microsatellite Instability-High Colorectal Cancer: An Integrated Single-Cell and Spatial Transcriptomics Study.

Journal: OncoTargets and therapy

Published: May 02, 2025

Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?

Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 24, 2025

Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial.

Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial.

Journal: Annals of surgical oncology

Published: April 16, 2025

Circulating Tumor DNA Predicts Conversion Therapy Response and Prognosis in Initially Unresectable Colorectal Liver-Limited Metastases: A Retrospective Study.

Circulating Tumor DNA Predicts Conversion Therapy Response and Prognosis in Initially Unresectable Colorectal Liver-Limited Metastases: A Retrospective Study.

Journal: British journal of hospital medicine (London, England : 2005)

Published: March 26, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026